Infographic. Cannabis residues in wastewater in selected European cities: most recent data (updated June 2024)
Publication date
Description
This resource is part of the European Drug Report 2024, the EMCDDA's annual overview of the drug situation in Europe.
Source data
Hidden tables for page
Term | Colour |
---|---|
increase | #f58466 |
stable | #fbaa19 |
decrease | #b3d455 |
no previous data | #7da7d9 |
Term | Filter sort |
---|---|
Resin | 1 |
Herbal | -1 |
Term | Filter sort |
---|---|
Resin | -1 |
Herbal | 1 |
ID | Term |
---|---|
0 | Close |
1 | Substance |
2 | Recall period |
3 | Age |
4 | Gender |
5 | Prevalence of drug use |
6 | Percent |
7 | Breakdown by substance |
8 | Prevalence all available countries |
9 | Trends |
11 | Males and females |
14 | Country |
15 |
Notes Prevalence data presented here are based on general population surveys submitted to the EMCDDA by national focal points. For the latest data and detailed methodological information please see the Statistical Bulletin 2024: Prevalence of drug use. Graphics showing the most recent data for a country are based on studies carried out between 2013 and 2023. Prevalence estimates for the general population: age ranges are 18-64 and 18-34 for Germany, Greece, France, Italy and Hungary; 16-64 and 16-34 for Denmark, Estonia and Norway; 18-65 for Malta; 17-34 for Sweden. |
16 | About the data |
17 | Currently not available for individual countries |
50 | Cannabis |
101 | prevalence of cannabis use |
102 | prevalence of cocaine use |
103 | prevalence of MDMA use |
104 | prevalence of amphetamine use |
105 | prevalence of methamphetamine use |
231 | Gender breakdown: all treatment entrants |
232 | Mean age: all treatment entrants |
233 | Client status – number of clients |
234 | First-time entrants |
235 | Previously treated entrants |
236 | Unknown status |
237 | Route of administration (%) |
238 | Injecting |
239 | Smoking/inhaling |
240 | Eating/drinking |
241 | Sniffing |
242 | Other |
243 | Frequency of use in the last month (%): all treatment entrants |
244 | 4 to 6 days per week |
245 | 2 to 3 days per week |
246 | Once a week or less |
247 | Not used in the last 30 days |
248 | Trends in first-time entrants |
250 | Cannabis market: data and trends |
252 | Years |
260 | Cannabis type |
261 | Daily |
265 | COVID-19 pandemic |
312 | Geographical coverage (selected graphs) |
315 | Number of seizures |
324 | Price retail (EUR/g) (EU) |
325 | Price wholesale (EUR/kg) (EU) |
330 | Quantity seized (tonnes) |
360 | Cannabis type |
370 | Potency retail (% THC) (EU) |
375 | Indexed trends, retail (2011=100) (EU) |
385 | Trends in number of seizures (x 1000) |
386 | Trends in quantity seized (tonnes) |
400 | mg/1000 population/day |
450 | Kilograms |
500 | Retail |
510 | Wholesale |
520 | Potency |
600 | cannabis |
610 | cocaine |
620 | amphetamine |
630 | methamphetamine |
640 | MDMA |
650 | ketamine |
100200 | Mean use: 4.3 days per week |
100201 | Mean use 3.3 days per week |
Term | Filter sort |
---|---|
Lifetime | 100 |
Last month | 1 |
Last year | 20 |
All adults (15-64) | 200 |
Young adults (15-34) | 10 |
Term | Filter sort |
---|---|
Cannabis | 1 |
Cocaine | -1 |
LSD | -1 |
Ecstasy | -1 |
Amphetamines | -1 |
Tobacco | -1 |
Alcohol | -1 |
Category | Filter sort |
---|---|
EU | 1 |
EU+2 | -1 |
Austria | 101 |
Belgium | 102 |
Bulgaria | 103 |
Croatia | 104 |
Cyprus | 105 |
Czechia | 106 |
Denmark | 107 |
Estonia | 108 |
Finland | 109 |
France | 110 |
Germany | 111 |
Greece | 112 |
Originally published in
European Drug Report 2024: Trends and Developments
Main subject
Target audience
Type
Copyright status
- Creative Commons Attribution 4.0 International (CC BY 4.0)
Related assets in the Media library
Previous slide
Next slide